NACINATE-120

NACINATE-120 Injection contains Artesunate, a fast-acting antimalarial medicine that is widely used in the management of severe and complicated malaria. It is particularly effective in infections caused by Plasmodium falciparum, where quick reduction of parasite load is essential to prevent further clinical deterioration.In real-world clinical practice, this injection is mainly used in hospital and emergency settings. It is preferred in situations where the patient presents with severe malaria symptoms and immediate intervention is required. In many cases, oral therapy is not feasible due to the patient’s condition, and injectable Artesunate becomes the treatment of choice.What makes NACINATE-120 important in critical care is its ability to act quickly and deliver a reliable therapeutic response, helping clinicians stabilize patients at an early stage of treatment.

Mechanism of Action

Once administered, Artesunate is rapidly converted into its active form, dihydroartemisinin, within the body. This active metabolite targets the malaria parasite directly.It works by producing reactive oxygen species inside the parasite, which damages vital proteins and disrupts essential cellular functions. As the parasite is unable to survive this damage, it is rapidly cleared from the bloodstream.This quick parasiticidal effect is one of the key reasons why Artesunate is preferred in severe malaria cases, where every hour of delay can impact patient outcomes.

Indications

NACINATE-120 is recommended in the treatment of:

• Severe malaria caused by Plasmodium falciparum
• Complicated malaria with systemic complications
• Cerebral malaria cases
• High parasitemia requiring urgent intervention
• Patients unable to take oral antimalarial therapy
• Hospital-based management of life-threatening malaria

In most cases, it is used as part of a complete antimalarial regimen guided by standard treatment protocols.

Key Benefits

• Valued in clinical practice for its fast and dependable action against malaria parasites

• Rapid onset of effect helps in quickly reducing parasite levels

• Plays an important role in stabilizing critically ill patients

• Widely accepted in hospital treatment protocols for severe and complicated malaria

• Trusted by physicians in emergency situations requiring immediate parasite control

• Supports faster clinical recovery through effective parasite clearance

• Formulated to ensure stable, consistent, and predictable therapeutic results

• Considered a reliable option in critical care and infectious disease management

Dosage and Administration

NACINATE-120 is administered either intravenously or intramuscularly under strict medical supervision in hospital settings.The exact dose is decided by the physician based on the patient’s body weight, severity of infection, and overall clinical condition. It is usually followed by a full course of oral antimalarial therapy as per established treatment guidelines.During treatment, patients are closely monitored to evaluate response and ensure safe and effective recovery.

Why Choose NACINATE-120?

NACINATE-120 is developed for situations where speed of action truly matters. In severe malaria, early and effective parasite clearance can make a significant difference in clinical outcomes.Its quick response, proven efficacy, and dependable performance make it a preferred choice in emergency and hospital care settings. Healthcare professionals trust Artesunate-based therapy like NACINATE-120 when dealing with life-threatening malaria cases that require immediate intervention.Overall, it stands as a reliable injectable antimalarial option that supports effective management of severe malaria in critical conditions.